During Arendalsuka 2019, we arranged a breakfast meeting on the development of cancer treatments of the future, together with LMI and Kreftforeningen. Arendalsuka has become an important arena for those who want to improve aspects of Norwegian society. We were there this year to meet key players to accelerate the development of cancer treatments. Our […]
Immunitrack has been awarded a grant from Eurostars to develop their prediction tool for cancer vaccines.
The Japanese tech giant NEC Corporation has acquired OncoImmunity AS.
Oslo Cancer Cluster Incubator collaborates with partners in Sweden, Norway and Finland to help life science professionals learn from their neighbours.
We proudly present the new members that have joined our organisation during the second quarter of 2019.
We are happy to welcome three new members to the board of Oslo Cancer Cluster. Find out what they had to say about entering their new positions.